These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26394703)

  • 21. Identifying molecular markers for the early detection of pancreatic neoplasia.
    Goggins M
    Semin Oncol; 2007 Aug; 34(4):303-10. PubMed ID: 17674958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of glycoscience to the early detection of pancreatic cancer.
    Miyoshi E; Kamada Y
    Cancer Sci; 2016 Oct; 107(10):1357-1362. PubMed ID: 27418030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
    Winter JM; Yeo CJ; Brody JR
    J Surg Oncol; 2013 Jan; 107(1):15-22. PubMed ID: 22729569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?
    Krantz BA; O'Reilly EM
    Clin Cancer Res; 2018 May; 24(10):2241-2250. PubMed ID: 29269376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of biological markers in Pancreatic Ductal Adenocarcinoma.
    Giovinazzo F; Turri G; Zanini S; Butturini G; Scarpa A; Bassi C
    Surg Oncol; 2012 Dec; 21(4):e171-82. PubMed ID: 22981281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of gene expression profiling of pancreatic cancer.
    Goonetilleke KS; Siriwardena AK
    Int J Surg; 2008 Feb; 6(1):81-3. PubMed ID: 18359465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of immunohistochemistry in the pancreatobiliary tract.
    Lin F; Chen ZE; Wang HL
    Arch Pathol Lab Med; 2015 Jan; 139(1):24-38. PubMed ID: 25549142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
    Mazur PK; Siveke JT
    Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer.
    Kim S; Kang M; Lee S; Bae S; Han S; Jang JY; Park T
    Biomed Eng Online; 2014; 13 Suppl 2(Suppl 2):S5. PubMed ID: 25560450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rare forms of the ductal carcinoma of the pancreas].
    Setdikova GR; Filippova EM; Paklina OV; Kriger AG; Chekmareva IA; Gorin DS; Berelavichus SV; Bedin VV; Tavobilov MM
    Khirurgiia (Mosk); 2013; (6):4-7. PubMed ID: 23887254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?
    Chandana S; Mahadevan D
    Expert Rev Mol Med; 2009 Nov; 11():e34. PubMed ID: 19919723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
    Connor AA; Gallinger S
    Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):683-694. PubMed ID: 28460572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis.
    Missiaglia E; Blaveri E; Terris B; Wang YH; Costello E; Neoptolemos JP; Crnogorac-Jurcevic T; Lemoine NR
    Int J Cancer; 2004 Oct; 112(1):100-12. PubMed ID: 15305381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
    Halbrook CJ; Lyssiotis CA
    Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.
    Scheiman JM; Hwang JH; Moayyedi P
    Gastroenterology; 2015 Apr; 148(4):824-48.e22. PubMed ID: 25805376
    [No Abstract]   [Full Text] [Related]  

  • 38. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
    Alemi F; Alseidi A; Scott Helton W; Rocha FG
    Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants.
    Giri B; Sethi V; Dudeja V; Banerjee S; Livingstone A; Saluja A
    Curr Opin Gastroenterol; 2017 Sep; 33(5):404-410. PubMed ID: 28682795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ductal pancreatic cancer in humans and mice.
    Tuveson DA; Hingorani SR
    Cold Spring Harb Symp Quant Biol; 2005; 70():65-72. PubMed ID: 16869739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.